Related by context. All words. (Click for frequent words.) 73 ALK inhibitors 72 NSCLC tumors 72 small molecule activators 71 chemopreventive agent 71 LHRH receptor positive 71 epithelial tumors 70 Upregulation 70 gastrointestinal stromal tumors GISTs 70 vivo validation 70 molecular biomarkers 70 predictive biomarkers 70 prognostic markers 70 druggable targets 70 kidney urologic 69 stratifying patients 69 molecular abnormalities 69 hypermethylated 69 Factor VIIa 69 genomic biomarker 69 cisplatin resistant 69 prognostic marker 69 antimitotic 69 diagnostic biomarkers 69 Clusterin 69 CCR1 69 HepDirect prodrug 69 biomarker identification 69 KRAS oncogene 69 gastric carcinoma 69 prognostic indicators 69 CYT# potent vascular disrupting 69 gefitinib Iressa 68 chemoresistant 68 anaplastic lymphoma kinase ALK 68 Gleevec resistant 68 Vidaza azacitidine 68 antisense inhibitors 68 receptor tyrosine kinase inhibitor 68 PARP inhibition 68 redox active 68 potently inhibit 68 prostate carcinoma 68 oxysterols 68 PIGF 68 multiplex assay 68 prognostic biomarker 68 BRAF V#E mutation 68 predictive biomarker 68 alpha fetoprotein AFP 68 serine protease 68 immune modulating 68 methylation markers 68 histone deacetylase HDAC 68 murine models 68 mutated K ras 68 Darapladib 68 annexin 68 PI3K AKT 68 CDK inhibitor 68 therapeutic monoclonal antibody 68 Locked Nucleic Acid LNA 68 transgenic mouse models 68 humanised antibody 67 mTOR inhibitors 67 chimeric monoclonal antibody 67 mediated inhibition 67 biomarker 67 liver metastasis 67 K ras mutations 67 potent inducer 67 nodal metastasis 67 thrombophilia 67 prognostic indicator 67 FLT3 67 MAPK pathway 67 targeted radiotherapeutic 67 breast cancer subtypes 67 artery embolization 67 GSK3B 67 gene amplification 67 tumorigenicity 67 A3 adenosine receptor 67 molecular diagnostic assay 67 isoform selective 67 myelofibrosis polycythemia vera 67 HER2 overexpression 67 Li Fraumeni 67 PI3K/mTOR 67 ADAMTS# 67 miRNA biomarkers 67 diagnose Alzheimer disease 67 potent inhibitors 67 extramedullary 67 prognostic biomarkers 67 pan HDAC inhibitor 67 neutrophil gelatinase associated lipocalin 67 inhibit angiogenesis 67 metalloprotease 67 DGAT1 67 squamous cell lung cancer 67 polycythemia vera PV 67 presymptomatic 67 susceptibility gene 67 Enzastaurin 67 SGLT2 inhibitors 67 chemokine receptor 67 Onconase 67 somatic mutations 67 tumor necrosis 67 HLA DQ2 67 SCD1 67 lymphoid tumors 67 lymphomas leukemias 67 idiopathic myelofibrosis 67 metastatic malignant 67 molecular determinants 67 metabolomic profiling 67 cathepsins 67 antiproliferative effects 67 aurora kinase 67 metastatic neuroendocrine tumors 67 unresectable tumors 67 hESC derived cardiomyocytes 67 targeted antifolate 67 nonhuman primate model 67 TPMT 67 histone deacetylase inhibitor 66 anti CD3 66 B7 H3 66 monogenic 66 LRP5 66 mucinous 66 Factor Receptor 66 Crizotinib 66 prostate cancer PCa 66 thalidomide Thalomid 66 Pertuzumab 66 antisense inhibitor 66 humanized monoclonal antibodies 66 antiangiogenic drugs 66 protein tyrosine phosphatase 66 microRNA biomarkers 66 trial evaluating PRX# 66 kinase inhibition 66 mTOR inhibition 66 edifoligide 66 Epstein Barr Virus EBV 66 Estrogen Receptor 66 selective modulator 66 p# inhibitor 66 splice variants 66 Immunotherapeutic 66 immune modulator 66 protein tyrosine phosphatase 1B 66 immunohistochemical 66 Chemokine Receptor 66 benign neoplasms 66 papillary renal cell carcinoma 66 vitro assay 66 serous ovarian cancer 66 Hutchinson Gilford progeria 66 flavopiridol 66 pre malignant lesions 66 chromosomal mutations 66 neovascularisation 66 small molecule agonists 66 T#I [002] 66 beta1 integrin 66 ADAM# 66 HCV polymerase 66 humanized antibody 66 GeneICE 66 KLF4 66 Immunohistochemical staining 66 microtubule inhibitor 66 Hedgehog inhibitor 66 HER2 neu 66 Protein Kinase C 66 etiologic factors 66 thyroid carcinoma 66 metabolomic profiles 66 malignant lymphomas 66 C5aR 66 anticancer therapeutics 66 antibody mediated 66 CXCR4 receptor 66 colorectal carcinoma 66 Modrenal 66 iPS derived 66 hematopoietic progenitor cells 66 COX2 66 Fibroblast Growth Factor Receptor 66 hPTH #-# 66 imatinib resistance 66 atherosclerosis regression 66 Surgical resection 66 CIN2 + 66 thromboembolic disease 66 multiplexed assays 66 PI3 kinase inhibitors 66 cardiac troponin 66 prostate cancer CaP 66 PI3K inhibitors 66 peptidic 66 antiangiogenic agent 66 retinoic acid receptor 66 RNAi therapeutic targeting 66 proliferative disorders 66 PDGF receptor 66 relapsed ALL 66 Dasatinib 66 demethylating agents 66 Curaxin 65 CTAP# Capsules 65 #beta HSD1 65 genetic biomarkers 65 Bucindolol 65 DNA methyltransferases 65 glycosylated 65 Interferon beta 65 BRAF mutation 65 Prognostic factors 65 malignant ascites 65 uPAR 65 primary hyperparathyroidism 65 renal carcinoma 65 Smac mimetics 65 biomarkers 65 gastric carcinomas 65 prostate carcinomas 65 adenomatous 65 radioimmunotherapy RIT 65 Kinase inhibitors 65 antithrombotic agents 65 FGFR1 65 leiomyomas 65 Tr DNA 65 irreversible inhibitor 65 endostatin 65 ANGPTL4 65 tumor histology 65 P#X# 65 aneuploidies 65 RT qPCR 65 colorectal adenoma 65 murine model 65 susceptibility loci 65 Aviptadil 65 ductal carcinomas 65 enzyme inhibitor 65 γ secretase 65 peptide BNP 65 Topoisomerase II 65 Fibroblast 65 kinase profiling 65 myeloperoxidase 65 ABL1 65 heparanase 65 rxRNA 65 microRNA expression 65 hypereosinophilic syndrome 65 cardiac troponin T 65 VEGF receptor 65 SSc 65 BrachySil ™ 65 thetreatment 65 ductal adenocarcinoma 65 CDX2 65 selective inhibitors 65 proteomic biomarkers 65 inhibit metastasis 65 urothelial cancer 65 pain palliation 65 syngeneic 65 MMP inhibitors 65 androgen receptor AR 65 MTHFR 65 demethylating agent 65 Epidermal Growth Factor Receptor 65 Squamous 65 histone deacetylase inhibitors 65 protein tyrosine 65 pathological hallmark 65 non coding RNA 65 vinca alkaloid 65 Temsirolimus 65 parthenolide 65 anti angiogenic drugs 65 INS# [001] 65 HER2 positive cancers 65 antiphospholipid syndrome 65 Immunohistochemical analysis 65 selectively inhibited 65 assay detects 65 FISH fluorescence 65 Fas ligand 65 etiologic agent 65 epigenetic therapies 65 chromosomal rearrangement 65 Squalamine 65 molecular biomarker 65 Epigenomics proprietary 65 uricase 65 choroidal vasculopathy 65 DGAT 65 EGFR HER2 65 neoplastic cells 65 ERK signaling 65 clonogenic 65 antiangiogenic therapy 65 Inhaled nitric oxide 65 HIV reverse transcriptase 65 antisense inhibition 65 nonviral 65 Glycosylation 65 Cathepsin B 65 Her2 positive 65 biomarker assay 65 Smac mimetic 65 Aplidin 65 synthetic analogues 65 CB2 receptor 65 Umbilical cord stem cells 65 suppresses tumor 65 Monoclonal antibody 65 NS#/#A protease 65 MGd 65 HER2 receptor 65 phosphate S1P 65 EGFR TKI 65 microRNA profiling 65 optical biosensors 65 siRNA knockdown 65 metastatic lymph nodes 65 sphingolipid 65 druggable target 65 isotypes 65 NKX#.# 65 virulence genes 65 Genetic variants 65 kallikrein 65 mda 7 65 novel peptide 65 HepG2 cells 65 metabonomics 65 WT1 65 ERBB2 65 protein biomarkers 65 immunotoxin 65 genetic loci 65 activin 65 benzimidazole 65 JAK inhibitors 65 vimentin 65 thymosin beta 4 65 colorectal carcinogenesis 65 CagA 65 tumor subtypes 65 acid phosphatase PAP 65 prostate cancer metastases 65 humanized monoclonal 65 delipidation 65 transgenic rats 65 Homspera TM 65 proteasome inhibitor 65 immunohistochemical staining 65 mGluR2 NAM 65 LPA receptors 65 compound AEZS 65 biologic pathways 65 #T# L1 65 histone deacetylase 65 radiation sensitizer 65 small molecule tyrosine 65 JAK2 inhibitor 65 biochemical marker 65 C. trachomatis 65 immunoregulatory 65 Anticalins R 65 genetic variants associated 64 Xanafide 64 mechanistic insights 64 JAK2 enzyme 64 CCR3 64 bladder ovarian 64 node metastasis 64 Aurora Kinase 64 poly ADP ribose polymerase 64 engineered RAP peptides 64 aggregated Abeta 64 EGFR TKIs 64 metaglidasen 64 TLE3 64 non nucleoside 64 Corus CAD 64 MAGE A3 ASCI 64 hapten 64 cholesteryl ester transfer 64 recurrent glioblastoma multiforme 64 intracellular bacteria 64 PALB2 64 promoter hypermethylation 64 axonal degeneration 64 orally bioavailable 64 C. pneumoniae 64 pancreatic ductal adenocarcinoma 64 MCF7 64 FGFs 64 N glycan 64 cell adhesion molecule 64 thrombin receptor 64 anti angiogenic therapy 64 PPARγ 64 proto oncogene 64 TGF alpha 64 bullous 64 pancreatic endocrine 64 catechol O methyltransferase 64 sonographic diagnosis 64 Beta catenin pathway 64 protein biomarker 64 urothelial carcinoma 64 receptor modulators 64 Leukemias 64 COL#A# 64 SNP rs# [001] 64 metastatic colorectal 64 Tasigna prolongs 64 acetylcholinesterase AChE 64 receptor ligand 64 allogeneic HSCT 64 cerebrospinal fluid CSF 64 riboflavin vitamin B2 64 metaplasia 64 skeletal metastases 64 estrogen receptor beta 64 necrotic core 64 eTag assays 64 cetuximab Erbitux 64 Fc gamma receptor 64 mitochondrial toxicity 64 accumulate preferentially 64 HG PIN 64 Treg cell 64 Cytochrome P# 64 Cardiotoxicity 64 Myeloperoxidase 64 Personalized Immunotherapy 64 MIF protein 64 chromosomal aberrations 64 androgen receptor antagonist 64 PPARg 64 Panzem NCD 64 etanercept Enbrel 64 normal karyotype 64 AGTR1 64 diabetic kidney 64 MEF2A 64 MELAS 64 histone deacetylases 64 clade B 64 Lymph node 64 transplantation HCT 64 BRCA1 BRCA2 64 bispecific antibody 64 hypervascular tumors 64 miRNA expression 64 Pseudomonas aeruginosa infections 64 Janus Kinase 64 Haptoglobin 64 ESBA# 64 alkylating agent 64 inhibit viral replication 64 ABCB1 64 KL4 Surfactant 64 hepatic lipase 64 retroviral vectors 64 histone deacetylase HDAC inhibitors 64 myeloproliferative diseases 64 G6PD deficiency 64 generation purine nucleoside 64 metabolizing enzyme 64 multicenter Phase II 64 p# mutations 64 Flt3 64 receptor mediated endocytosis 64 Hsp# inhibition 64 bronchial epithelial cells 64 serologic tests 64 SERMs 64 microdeletions 64 chronic myeloid 64 Leydig cell 64 lupus anticoagulant 64 Trofex 64 androgen dependent 64 hedgehog signaling pathway 64 complement inhibitor eculizumab 64 lysosomal enzyme 64 protein CETP 64 Ceflatonin 64 oral squamous cell 64 Deforolimus 64 diagnostic modality 64 mGlu2 3 64 subcutaneous immunoglobulin 64 drug zotarolimus 64 FUS1 64 cytokine receptor 64 gonococcal 64 eicosanoid 64 tumor biopsies 64 S. maltophilia 64 Endometrial 64 Safinamide 64 5 HT2A serotonin 64 JAK3 64 haematologic 64 synovial cells 64 receptor blocker 64 anti infective treatments 64 Kinoid 64 neuronal nicotinic receptor NNR 64 neurokinin 1 64 DXL# 64 isotype 64 FGFR3 64 ErbB2 positive 64 radiolabeled antibodies 64 recurrent ovarian 64 caspofungin 64 liposomal formulation 64 VA# [002] 64 Fingolimod 64 gastric adenocarcinoma 64 MTP inhibitor 64 peptide conjugated 64 orally administered inhibitor 64 depsipeptide 64 NS4B 64 immunodeficiency disorders 64 Alfacell proprietary ribonuclease 64 hypermethylation 64 secretory pathway 64 potent antiproliferative 64 selective inhibition 64 pretransplant 64 metastatic gastric 64 AFREZZA TM 64 arterial calcification 64 KRAS mutation 64 molecularly targeted therapy 64 CDK4 64 plasma kallikrein 64 cyclin dependent kinase inhibitor 64 PTPN# 64 BRCA mutation carriers 64 genomic alterations 64 verteporfin 64 PIK3CA 64 CBLC# 64 miRNA profiling 64 4E BP1 64 gamma secretase inhibitor 64 NEUGENE R 64 basal cell carcinoma BCC 64 hA# 64 Abiraterone 64 atypical hemolytic uremic syndrome 64 tumor hypoxia 64 endoglin 64 renin inhibitors 64 mimetics 64 PDE# inhibitors 64 telomerase inhibitor 64 pediatric malignancies 64 cyclophilin inhibitors 64 p# biomarker 64 pancreatic islet 64 anti angiogenic agents 64 urothelial bladder cancer 64 RNAi therapeutic targeting PCSK9 64 Akt inhibitor 64 Septin9 64 bronchogenic carcinoma 64 alpha1 antitrypsin deficiency 64 validate biomarkers 64 antitumour 64 lymphatic vessel 64 phosphorylated proteins 64 DCVax R 64 systemic amyloidosis 64 sequence homology 64 endocrine therapies 64 Her2/neu 64 HGPIN 64 induces apoptosis 64 sarcosine 64 CMV infections 64 susceptibility locus 64 ENMD # 64 BRCA deficient 64 Annexin V 64 phosphoprotein 64 peptide antigens 64 tumor specific antigen 64 Liposomal 64 HER2 expression 64 immunopathology 64 prostate adenocarcinoma 64 cathepsin K 64 Epstein Barr virus EBV 64 hepatocellular carcinomas 64 factor receptor FGFR 64 OXIGON TM 64 neuronal nicotinic receptors NNRs 64 tubulin inhibitor 64 BRAF V#E 64 inhibitor rofecoxib 64 abacavir Ziagen 64 esophageal gastric 64 neuropsychiatric diseases 64 Lymphoid 64 Microalbuminuria 64 nucleotide analog 64 tyrosine kinase receptor 64 GCase 64 5 HT4 64 neuroendocrine cancers 64 myeloproliferative 64 SMAD4 64 cMET 64 chronic granulomatous disease 64 Allogeneic 64 ADPKD 64 potent suppressor 64 precursor lesions 64 scintigraphic 64 multikinase inhibitor 64 DNA intercalator 64 blood clotting protein 64 Anticalins ® 64 immunohistochemical analysis 64 placental cells 64 neuroregenerative 64 breast cancer metastasis 64 lymphatic vasculature 64 Elevated serum 64 PITX2 64 hepatocellular carcinoma liver 64 Xenopus embryos 64 IDH1 mutation 64 proteasome inhibitors 64 immuno modulatory 64 receptor inhibitor 64 genetic polymorphisms 63 dasatinib Sprycel 63 imatinib Gleevec ® 63 neurotrophic 63 E#F# 63 Osteopontin 63 PCA3 gene 63 gene rearrangements 63 #F FDG PET 63 endothelin receptor 63 inverse agonist 63 Hematopoietic 63 chronic thromboembolic pulmonary 63 vestibular schwannomas 63 novel VDA molecule 63 THR beta agonist 63 cardiotoxic 63 Olaparib 63 leukocyte adhesion 63 eIF 4E 63 Preclinical studies suggest 63 DNA methylation patterns 63 serum biomarkers 63 IGFBP2 63 phenotypic expression 63 generation antisense inhibitor 63 microsatellite instability 63 acadesine 63 DFMO 63 M2 subunit 63 siRNAs targeting 63 gene expression microarray 63 nucleoside analogues 63 osteoprotegerin 63 nonnucleoside reverse transcriptase inhibitors 63 virus AAV 63 treating neuropathic pain 63 vidofludimus 63 nicotinic receptor 63 pyruvate kinase 63 lung carcinomas 63 NeoLipid R 63 pDCs 63 DNA methylation markers 63 circulating endothelial cells 63 Camptothecin 63 NF kB pathway 63 pleiotropic 63 miRview TM mets 63 proteoglycan 63 Bioral ® 63 neuronal dysfunction 63 somatostatin receptors 63 selectively inhibiting 63 GIST tumors 63 cellular immunotherapy 63 trophoblastic 63 FTIs 63 Aromatase 63 cardiometabolic disorders 63 BrachySil TM 63 nucleotide analogs 63 immunochemical fecal occult 63 glutamyl 63 etiologic 63 constitutively expressed 63 nucleoside analogs 63 invasive lobular 63 EGFR receptor 63 HER2 ErbB2 63 glutamic acid decarboxylase 63 pulmonary metastases 63 haematopoietic 63 Vascugel ® 63 TMEM#B 63 pathogenetic 63 TMPRSS2 ERG fusion 63 mGluR5 antagonist 63 endophenotypes 63 florbetaben 63 hematopoietic cancers 63 ALK inhibitor 63 mouse xenograft models 63 delafloxacin 63 hormone receptor negative 63 BRAF inhibitors 63 PTP 1B 63 Leydig cells 63 AAV vectors 63 micrometastasis 63 gene loci 63 antiangiogenesis 63 inhibit enzymes 63 IAP inhibitor 63 Prodarsan ® 63 pediatric acute lymphoblastic 63 NPM1 63 Azacitidine 63 PNP inhibitor 63 interleukin IL -# 63 motor neuron degeneration 63 gp# protein [002] 63 Bezielle 63 pancreatic lung 63 vemurafenib 63 melanocortin receptor 63 investigational humanized monoclonal antibody 63 Src inhibitors 63 upregulates 63 ultrasonographic examination 63 prostanoid 63 lymphoid cells 63 carcinoembryonic antigen 63 Angiotensin Converting Enzyme 63 Pathway Inhibitor 63 novel therapeutic antibodies 63 leukemia AML 63 Western blotting 63 Janus kinase 63 K ras 63 serine threonine kinase 63 XYOTAX TM 63 immunochemical 63 oral Janus kinase 63 matrix metalloproteinases 63 pulmonary metastasis 63 ALK mutations 63 breast carcinoma 63 radiosensitivity 63 operable breast cancer 63 basal cell nevus syndrome 63 β1 63 IMA# 63 Lisofylline 63 pleiotropic effects 63 fallopian tube cancers 63 fluoroquinolone resistance 63 anti CD3 antibody 63 small molecule activator 63 pancreatic prostate 63 von Hippel Lindau 63 HCV replication 63 gastrointestinal stromal tumors GIST 63 Cytomegalovirus CMV 63 neuroprotectant 63 either acutely decompensated 63 Kinase Inhibitor 63 lung fibrosis 63 ON #.Na 63 nutlin 3a 63 immunomodulatory properties 63 paraganglioma 63 potent stimulator 63 chlamydial 63 rBChE 63 IGF IR 63 Curaxin CBLC# 63 #q# deletion 63 ATIR 63 antibody MAb 63 biliary tract cancer 63 imatinib Gleevec 63 symptomatic paroxysmal AF 63 proteasome inhibition 63 cytogenic 63 vaso occlusive crisis 63 fibrin deposition 63 neuroblastoma tumors 63 RNase L 63 splice junctions 63 efaproxiral 63 sd rxRNA 63 EGFR pathway 63 TÎ ² 4 63 targeted nucleotide prodrug 63 beta secretase inhibitors 63 Papillary 63 TriGrid ™ 63 protein biochip 63 ERalpha 63 hepatoma 63 gastrin 63 GISTs 63 p# activation 63 acetylcholine receptor 63 pharmacological inhibition 63 serotonin uptake 63 lung pancreatic 63 JAK2 inhibitors 63 GRNCM1 63 myopathies 63 selectively inhibit 63 eflornithine 63 covalently bound 63 neuroinflammation 63 NMDA antagonist 63 recurrent glioblastoma multiforme GBM 63 OGG1 63 menstrual stem cell 63 NB S# strontium malonate 63 carcinoids 63 cardioprotective effects 63 protein kinase inhibitors 63 FGF signaling 63 p#/CBP 63 radiotherapeutic 63 Cyclosporin 63 impair fertility 63 pretargeting 63 Cyclin E 63 CD4 + T lymphocytes 63 Fc fusion protein 63 cyclic peptide 63 bardoxolone methyl 63 Tyrima 63 Cystatin C 63 Enkephalin 63 erlotinib Tarceva 63 Cellcept 63 validating biomarkers 63 pharmacologic intervention 63 myeloproliferative disorders 63 antitumoral 63 pan genotypic 63 diabetes mellitus DM 63 selective kinase inhibitor 63 RRM1 63 pDC 63 peroxisomal 63 Wnt signaling pathway 63 HMGCR 63 biochemical assays 63 relapsed ovarian cancer 63 NV1FGF 63 genomewide 63 humanised monoclonal antibody 63 immunotherapeutic approaches 63 humoral responses 63 CA9 SCAN 63 genetic polymorphism 63 DCVax 63 Sudhir Agrawal D.Phil 63 EP #R 63 Hashimoto thyroiditis 63 HLA genotyping 63 CCL# 63 MYCN amplification 63 Alzheimer Disease AD 63 Fibroblasts 63 mediated apoptosis 63 Immunoassays 63 GSTP1 63 MSH2 63 anti fibrotic 63 proteomic analysis 63 transcranial Doppler ultrasound 63 tiapamil 63 NOD SCID mice 63 Angiotensin converting enzyme 63 c myc gene 63 oral prodrug 63 lysophosphatidic acid 63 Vidaza ® 63 colorectal adenocarcinoma 63 vaginalis 63 causative genes 63 SYN# 63 bladder carcinoma 63 granzyme B 63 Trichomonas vaginalis 63 Oncogenic 63 PCR assay 63 Angiolix 63 antifibrotic 63 serum biomarker 63 cyclin E 63 neuroendocrine carcinoma 63 mutant KRAS 63 tryptase 63 amine oxidase 63 demonstrated antitumor activity 63 chemosensitivity 63 adipogenic 63 adipose derived regenerative 63 p# mitogen activated 63 percutaneous biopsy 63 HbF 63 pharmacological chaperone 63 Monocyte 63 ATTR CM 63 NS3 protease 63 colon carcinoma 63 vascular disrupting agents 63 glycopeptides 63 5alpha reductase 63 PET tracers 63 quinacrine 63 genomic profiling 63 histone acetyltransferase 63 reversible inhibitor 63 transcriptomics 63 eosinophil count 63 CCR5 inhibitor 63 bortezomib Velcade 63 mimetic compounds 63 thymidine kinase 63 alpha fetoprotein 63 selective antagonist 62 STK# [002] 62 transfusion syndrome 62 aneuploid 62 Circulating tumor cells 62 miglustat 62 monoclonal anti 62 TTR gene 62 circadian genes 62 thrombopoietin TPO 62 NeoLipid TM 62 colorectal liver metastases 62 ankyrin repeat 62 PAR1 62 lung metastasis 62 RAF kinase 62 osteogenic 62 recombinant antibodies 62 thromboxane A2 62 diagnose coronary artery 62 endometrial hyperplasia 62 polycythemia vera essential thrombocythemia 62 T SPOT.TB 62 HepDirect technology 62 Lodamin 62 VeriStrat 62 castrate resistant prostate cancer 62 PEDF 62 CD# expression [001] 62 Mesenchymal 62 intestinal mucosal 62 miRview ™ squamous 62 p# MAPK 62 Lp PLA 2 62 invasive ductal 62 AKT inhibitor 62 bispecific